加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
KTD3003 SDS-PAGE蛋白上样缓冲液(5X) miR-9 targeting RUNX1 improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS 6 International Immunopharmacology
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) Synergistic effects of dihydroartemisinin and cisplatin on inducing ferroptosis in gastric cancer through GPX4 inhibition. 6 Gastric Cancer
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) CAG peptide functionalized graphene quantum dots-cationic polymer composite gene carriers. 6 Journal of Materials Chemistry B
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) Dihydroartemisinin inhibited vasculogenic mimicry in gastric cancer through the FGF2/FGFR1 signaling pathway. 7 Phytomedicine
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) Ivermectin inhibits the growth of ESCC by activating the ATF4-mediated endoplasmic reticulum stress-autophagy pathway." Acta biochimica et biophysica Sinica (2024). 3 Acta biochimica et biophysica Sinica
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) CNPY2 governs PDGF‑BB‑treated vascular smooth muscle cell proliferation, migration and phenotypic transformation via the Akt/mTOR/GSK‑3β signaling pathway. 2 Experimental and Therapeutic Medicine
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) Remodeling of the pro-inflammatory microenvironment in osteoarthritis via hydrogel-based photothermal therapy. 23 Advanced Composites and Hybrid Materials
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) Ribosome-targeting antibiotic control NLRP3-mediated inflammation by inhibiting mitochondrial DNA synthesis. 7 Free Radical Biology and Medicine
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) HOXB2 promotes cisplatin resistance by upregulating lncRNA DANCR in ovarian cancer. 4  Journal of Ovarian Research
KTA2030 EdU法细胞增殖成像分析试剂盒(绿色荧光) Liu, Lili, et al. "Cyanidin‐3‐O‐Glucoside Combined with PGC1α Inhibitor Promotes Cancer Cell Death by Inducing Excessive Levels of ROS in Cervical Squamous Cell Carcinoma." Journal of Food Biochemistry 2024.1 (2024): 4953859. 4 Journal of Food Biochemistr
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部